Skip to content

SPP closes at 5pm AWST Wed 25th Nov 2026  Learn more    

Unique panel of biomarkers identified for oesophageal cancer

Proteomics International Managing Director Dr Richard Lipscombe said the research studied multiple proteins in the blood associated with early-stage oesophageal adenocarcinoma. “From these, we’ve been able to identify a select panel of biomarkers with the potential to be used as a diagnostic test. Importantly we have also completed validation of the panel using blood samples from more than 300 patients.”

ASX Release